Your browser doesn't support javascript.
loading
The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation.
Deuse, Tobias; Hua, Xiaoqin; Stubbendorff, Mandy; Spin, Joshua M; Neofytou, Evgenios; Taylor, Vanessa; Chen, Yan; Park, Gary; Fink, James B; Renne, Thomas; Kiefmann, Martina; Kiefmann, Rainer; Reichenspurner, Hermann; Robbins, Robert C; Schrepfer, Sonja.
Affiliation
  • Deuse T; 1 TSI Laboratory, University Heart Center Hamburg, Hamburg, Germany. 2 Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Luebeck, Hamburg, Germany. 3 Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany. 4 Department of Surgery, TSI Laboratory, University of California San Francsico (UCSF), San Francsico, CA. 5 Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, Stanfo
Transplantation ; 100(5): 1022-31, 2016 05.
Article in En | MEDLINE | ID: mdl-26910327
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Trachea / Bronchiolitis Obliterans / Protein Kinase Inhibitors / Janus Kinase 1 / Janus Kinase 3 / Immunosuppressive Agents Limits: Animals / Humans Language: En Journal: Transplantation Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Trachea / Bronchiolitis Obliterans / Protein Kinase Inhibitors / Janus Kinase 1 / Janus Kinase 3 / Immunosuppressive Agents Limits: Animals / Humans Language: En Journal: Transplantation Year: 2016 Type: Article